Press releases • Dec 04, 2019 10:01 UTC
Up to one in four infants globally suffer from excessive crying and fussing – often called colic. A new study shows that the BB-12® probiotic strain may help reduce crying duration and the number of crying episodes and bring relief to infants and their parents
Bevilling fra Innovationsfonden til udviklingen af næste generations mikrobielle løsninger til landbruget
Press releases • Nov 06, 2018 07:41 UTC
Innovationsfonden har ydet en bevilling til Chr. Hansen, Københavns Universitet og Dansk Teknologisk Institut (DTI), som sammen vil arbejde på at udvikle naturlige løsninger til en bæredygtig landbrugsproduktion
Press releases • Nov 06, 2018 07:29 UTC
The Danish Innovation Fund has awarded a grant to Chr. Hansen, University of Copenhagen and the Danish Technological Institute (DTI) who will join forces to develop natural solutions for sustainable agricultural production
Press releases • Jun 07, 2018 11:31 UTC
Chr. Hansen and FMC Corporation have announced a five-year extension of their collaboration to develop and commercialize natural solutions for the agricultural industry
Press releases • May 15, 2018 09:57 UTC
Clinical trial demonstrates that probiotic strain strengthens the defense against gut damage caused by regular use of household painkiller
Press releases • Apr 18, 2018 03:57 UTC
Prota Therapeutics, the developer of oral immunotherapies to treat food allergies, has partnered with Chr. Hansen. The partnership will assess the world’s best documented probiotic strain, LGG®, in a Phase III clinical trial to develop a treatment for peanut allergy.
Press releases • Oct 25, 2017 06:04 UTC
- Delivering on operational and strategic priorities while continuing to build long-term growth
Press releases • Jul 07, 2017 11:44 UTC
GalliPro® Fit is a uniquely formulated probiotic combining three novel strains into one product, creating a 3-in-1 solution for some of the poultry industry’s biggest challenges.
Press releases • Jun 12, 2017 10:47 UTC
Research on the human microbiome has exploded in recent years revealing it to be of major importance for human health and disease, creating opportunities for development of next generation probiotics. That is why Chr. Hansen is proud to announce that we have now expanded our world class strain library of potential microbiome modulating strains.
Chr. Hansen will showcase research on its newest Swine probiotic at the Congress on Gastrointestinal Function in Chicago
Press releases • Apr 12, 2017 08:34 UTC
Research confirming the effective in vitro inhibition of the growth of E. coli will be showcased at the Congress on Gastrointestinal Function, where other central studies with livestock and poultry species for food production and biomedical research, as well as clinical and nutritional studies relevant to improving human health and well-being will be presented.
Press releases • Jan 18, 2017 14:36 UTC
New research confirms hatch-to-market benefits of probiotics in poultry production.
To further strengthen its probiotics offering Chr. Hansen acquires LGG®, the world’s best documented probiotic strain, from Valio OY
Press releases • Sep 13, 2016 06:02 UTC
Natural solutions that advance human health are in high demand and the expected growth for microbial solutions in this industry is 7-9%. Chr. Hansen is the world’s leading supplier of probiotics to dietary supplements, infant formula and dairy, and through the acquisition of the LGG® business, the company is now further strengthening its microbial platform across all three categories.
Press releases • Jan 20, 2016 12:58 UTC
Studies show broilers fed probiotics maintain performance on energy-reduced diets.
Chr. Hansen enters first collaboration on production of a next generation probiotic from the Human Microbiome
Press releases • Jan 14, 2016 07:08 UTC
Today, Chr. Hansen and Caelus Health announce their collaboration on the development of Eubacterium hallii as a next generation probiotic for prevention and treatment of metabolic disease.
Chr. Hansen to acquire Nutritional Physiology Company and expand its business in probiotics to the livestock industry
Press releases • Jan 13, 2016 17:04 UTC
At Chr. Hansen, the animal health and nutrition business supplies probiotics to various customers in the global livestock industry. Through the acquisition of US-based Nutritional Physiology Company (NPC), Chr. Hansen will further broaden this microbial platform and expand its presence into the beef cattle segment.
One of the world's largest clinical studies on probiotics reinforces significant gastrointestinal benefits of the probiotic strain named BB-12®
Press releases • Sep 25, 2015 10:39 UTC
Millions of people around the world suffer from a range of gastrointestinal symptoms. Results from one of the world’s largest clinical studies on probiotics now show that the probiotic strain named BB-12® can be part of the solution by improving bowel regularity.
New clinical study indicates: probiotics may shorten duration of common cold and lower use of health care resources
Press releases • May 21, 2015 06:57 UTC
With the completion and publication of the world’s largest clinical study on the immune effect of probiotics in adults, Chr. Hansen has obtained results indicating that the probiotic strain named L. CASEI 431® can shorten the duration of common cold and influenza-like illness, lower the use of health care resources and reduce use of antibiotics.
Press releases • Oct 03, 2014 08:46 UTC
Chr. Hansen launches ‘Mother’s 1st‘, a convenient soft gel supplement combining probiotics and omega-3. Mother’s 1st is developed specifically to support immune and gut health in pregnant and lactating women as well as early brain and eye development in infants.